Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: Prevalence, relevance, and impact on organ allocation

Transplantation

Volumn 98, Issue 7, 2014, Pages 738-744

  Visentin, Jonathan ^a,b   Guidicelli, Gwendaline ^a   Bachelet, Thomas ^b   Jacquelinet, Christian ^c   Audry, Benoît ^c   Nong, Thoa ^d   Dubois, Valérie ^e   Moreau, Jean François ^a,b   Lee, Jar How ^d   Couzi, Lionel ^a   Merville, Pierre ^a,b   Taupin, Jean Luc ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Service de régulation et d'appui Île de France Agence de la biomédecine Centre Antilles Guyane   (France)

^d One Lambda Inc   (United States)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Denatured HLA antibodies; HLA antibodies; Ibeads; Kidney transplantation; Transplant allocation

Indexed keywords

DENATURED CLASS 1 HUMAN LEUKOCYTE ANTIGEN ANTIBODY; HLA ANTIBODY; HLA ANTIGEN CLASS 1; UNCLASSIFIED DRUG; ALLOANTIBODY; ANTIBODY; ANTIGEN;

ADULT; ARTICLE; BLOOD GROUP TYPING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GRAFT RECIPIENT; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN ALLOCATION; ORGAN DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE; ACUTE KIDNEY INJURY; ALLELE; BLOOD; CHEMISTRY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KIDNEY; PROCEDURES; TRANSPLANTATION;

ACUTE KIDNEY INJURY; ALLELES; ANTIBODIES; ANTIGENS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; PREVALENCE; RETROSPECTIVE STUDIES; TISSUE AND ORGAN PROCUREMENT;

EID: 84925547034     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000229     Document Type: Article

References (31)

1. Bray RA, Nolen JD, Larsen C, et al. Transplanting the highly sensitized patient: The emory algorithm. Am J Transplant 2006; 6: 2307.
2. Cecka JM, Kucheryavaya AY, Reinsmoen NL, et al. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant 2011; 11: 719.
3. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, et al. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111.
4. El-Awar N, Terasaki PI, Nguyen A, et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009; 70: 844.
5. Springer S, Doring K, Skipper JC, et al. Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. Biochemistry 1998; 37: 3001.
6. Kurimoto E, Kuroki K, Yamaguchi Y, et al. Structural and functional mosaic nature of MHC class I molecules in their peptide-free form. Mol Immunol 2013; 55: 393.
7. Bouvier M, Wiley DC. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer. Nat Struct Biol 1998; 5: 377.
8. Zacharias M, Springer S. Conformational flexibility of the MHC class I alpha1-Alpha2 domain in peptide bound and free states: A molecular dynamics simulation study. Biophys J 2004; 87: 2203.
9. Polakova K, Karpatova M, Russ G. Dissociation of beta 2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol 1993; 30: 1223.
10. Perosa F, Luccarelli G, Prete M, et al. Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10- specific peptide. J Immunol 2003; 171: 1918.
11. Sumitran-Karuppan S, Moller E. Acid treatment of lymphocytes selectively decreases the expression of HLA class I antigens: A method to confirm that a positive clinical crossmatch test was due to class I antibodies. Transpl Immunol 1996; 4: 163.
12. Danliczyk UG, Delovitch TL. Beta 2-microglobulin induces a conformational change in an MHC class I H chain that occurs intracellularly and is maintained at the cell surface. J Immunol 1994; 153: 3533.
13. Cai J, Terasaki PI, Anderson N, et al. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009; 88: 226.
14. Otten HG, Verhaar MC, Borst HP, et al. The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation. Clin Exp Immunol 2013; 173: 536.
15. Jacob EK, De Goey SR, Gandhi MJ. Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol 2011; 25: 77.
16. Nikaein A, El-Awar N, Hunt J, et al. Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices. J Heart Lung Transplant 2012; 31: 443.
17. Pereira S, Perkins S, Lee JH, et al. Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? HumImmunol 2011; 72: 492.
18. Hirata AA, Terasaki PI. Cross-reactions between streptococcal M proteins and human transplantation antigens. Science 1970; 168: 1095.
19. Hirata AA, McIntire FC, Terasaki PI, et al. Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation 1973; 15: 441.
20. Archer JR. Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae. Ann Rheum Dis 1981; 40: 400.
21. Gross U, Chen JH, Kono DH, et al. A ribosomal protein of Yersinia pseudotuberculosis having partial epitope identity with HLA-B27. Autoimmunity 1990; 7: 267.
22. Ravindranath MH, Kaneku H, El-Awar N, et al. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti- HLA-E-positive sera. J Immunol 2010; 185: 1935.
23. Mohan S, Palanisamy A, Tsapepas D, et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012; 23: 2061.
24. Schnabl E, Stockinger H, Majdic O, et al. Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2- microglobulin. J Exp Med 1990; 171: 1431.
25. Pickl WF, HolterW, Stockl J, et al. Expression of beta 2-microglobulinfree HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers. Immunology 1996; 88: 104.
26. Bodnar A, Bacso Z, Jenei A, et al. Class I HLA oligomerization at the surface of B cells is controlled by exogenous beta(2)-microglobulin: implications in activation of cytotoxic T lymphocytes. Int Immunol 2003; 15: 331.
27. Bachelet T, Couzi L, Guidicelli G, et al. Anti-Cw donor-specific alloantibodies can lead to positive flow cytometry crossmatch and irreversible acute antibody-mediated rejection. Am J Transplant 2011; 11: 1543.
28. Tran TH, Dohler B, Heinold A, et al. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants. Transplantation 2011; 92: 419.
29. Tait BD, Susal C, Gebel HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013; 95: 19.
30. Susal C, Ovens J, Mahmoud K, et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-Antigen testing: A Collaborative Transplant Study report. Transplantation 2011; 91: 883.
31. Couzi L, Araujo C, Guidicelli G, et al. Interpretation of positive flow cytometric crossmatch in the era of the single-Antigen bead assay. Transplantation 2011; 91: 527.